COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > For CZO shareholders

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Jun 07, 2024 8:58am

141 Views

Post# 36077125

For CZO shareholders

Schellaj wrote:My shares though BMO Investorline have yet to be switched over as well. No response from Ceapro either. Not a very comfortable situation right now.

Some CZO shareholders hadn't received their shares yet...

CZO's Feb.15, 2024 SEDAR filing said:

Non-Registered Shareholders The exchange of Shares for the Consideration Shares in respect of Non-Registered Shareholders is expected to be made with such Shareholders’ Intermediary. Non-Registered Shareholders should contact their Intermediary if they have any questions regarding this process and carefully follow the instructions from the Intermediary that holds their Shares and arrange for their Intermediary to complete the necessary steps to ensure that they receive the Consideration for their Shares as soon as possible following completion of the Arrangement

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks